Milne Mclean George's Insider Trades & SAST Disclosures
Milne Mclean George's most recent trade in Amylyx Pharmaceuticals Inc was a trade of 27,910 Common Stock done . Disclosure was reported to the exchange on Jan. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Milne Mclean George.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Jan 2025 | 27,910 | 830,661 | - | 0 | Common Stock | |
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 03 Sep 2024 | 100,000 | 858,571 | - | 2.2 | 219,800 | Common Stock |
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Amylyx Pharmaceuticals Inc | Milne Mclean George | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Jan 2024 | 9,100 | 758,571 | - | 0 | Common Stock | |
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Jan 2024 | 94,350 | 767,671 | - | 0 | Common Stock | |
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 16,985 | 16,985 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | George Mclean Milne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 8,733 | 78,733 (0%) | 0% | - | Common Stock | |
| Aurinia Pharmaceuticals Inc | George Mclean Milne | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 8,733 | 0 | - | - | Restricted Stock Units | |
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | Sale of securities on an exchange or to another person at price $ 31.86 per share. | 16 Mar 2023 | 33,084 | 863,937 | - | 31.9 | 1,053,901 | Common Stock |
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | Sale of securities on an exchange or to another person at price $ 32.45 per share. | 16 Mar 2023 | 1,916 | 862,021 | - | 32.4 | 62,172 | Common Stock |
| Aurinia Pharmaceuticals Inc | George Mclean Milne | Director | Purchase of securities on an exchange or from another person at price $ 8.91 per share. | 02 Mar 2023 | 20,000 | 70,000 (0%) | 0% | 8.9 | 178,284 | Common Stock |
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | 31 Dec 2022 | 689,425 | 910,821 | - | - | Common Stock | ||
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | 31 Dec 2022 | 384,449 | 0 | - | - | Series B Preferred Stock | ||
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | 31 Dec 2022 | 262,282 | 0 | - | - | Series A Preferred Stock | ||
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | 31 Dec 2022 | 23,212 | 0 | - | - | Series C-2 Preferred Stock | ||
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | 31 Dec 2022 | 19,482 | 0 | - | - | Series C-1 Preferred Stock | ||
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 13,800 | 897,021 | - | 0 | Common Stock | |
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Aurinia Pharmaceuticals Inc | George Mclean Milne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 14,612 | 14,612 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | George Mclean Milne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 8,733 | 8,733 | - | - | Restricted Stock Unit | |
| Aurinia Pharmaceuticals Inc | George Mclean Milne | Director | Purchase of securities on an exchange or from another person at price $ 10.82 per share. | 04 Mar 2022 | 5,000 | 50,000 (0%) | 0% | 10.8 | 54,100 | Common Stock |
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 06 Jan 2022 | 26,315 | 221,396 | - | 19 | 499,985 | Common Stock |
| Amylyx Pharmaceuticals Inc | George Mclean Milne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 8,400 | 8,400 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges